Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizPatent reform. Leahy/Hatch credibility on the line.
By Lawrence B. Ebert, Esq.
There are four major areas of disagreement between the industry groups.
These include changing how damages are awarded in patent infringement cases, the ability to challenge a patent's legitimacy, penalties for those who provide inaccurate or false information to the U.S. Patent and Trademark office and limiting the jurisdictions where patent challenges can be made.
Those familiar with the negotiations say that substantial progress has been made on all the disputed parts of the bill but damages for patent infringement, the most contentious remaining issue.
"The most difficult issue to try and get resolution on is damages," said Gary Griswold, chairman of the Coalition for 21st Century Patent Reform. "We are concerned there will be a reduction in the size of damages that can be awarded."
The story begins:
A renewed push by two veteran U.S. senators [Leahy, Hatch] could revive legislation aimed at overhauling the U.S. patent system, months after some had given the bill up for dead.
The next few weeks will be critical to the legislation, which the House passed in September. Although much of the discussion has focused on the different perspectives and concerns that the high tech and the biotech/pharma industries have about the legislation, the fact remains that the patent litigation system is broken. Congress should make every effort to fix it by writing into this legislation reasonable formulas for damage awards and venue rules that discourage forum-shopping. ...
Not a word about post-grant review [opposition].
CNET merely presented irrational raving:
The sooner we have a valid system for awarding patents, the better. As it stands right now all a person has to do to get a patent is to file the patent application and pay the fees. The patent will be granted without any scrutiny.
A patent should be almost impossible to obtain. Only the most novel ideas deserve patent protection. Obvious, trivial, and incremental ideas should be discarded from patent consideration.
IPBiz notes that the CNET post seems to suffer from belief in the Quillen/Webster (alleged) grant rate of 97%. The current grant rate is slightly over 50%.
Full post as published by IPBiz on February 22, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Texas, USA
alleging the Medical Malpractice and Tort Reform Act of 2003 violates several provisions of the Constitution.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Air Line Bankruptcy
BCI Aircraft Leasing agrees to pay $600,000 settlement related to Delta Air Lines bankruptcy claims.
Merger Agreement Rejected
Finish Line and Genesco reach $175 million settlement in merger dispute.

Leahy and Hatch on Patent Reform Act of 2007 - were making progress beacuse no one is entirely happy
Leahy, Hatch Address Patent Reform Act for 2008
Follow the MoneyPatent Prospector









